Current Affairs-Topics

India TB Report 2024: 16% Decrease in TB Cases

India has seen a 16% decline in TB incidence from 2015 to 2022, surpassing the global decline of 9%. The country notified 25.55 lakh cases of TB in 2023.

Declining Tuberculosis Incidence in India

India has made significant progress in its fight against tuberculosis (TB), with the country witnessing a 16% decline in TB incidence from 2015 to 2022, surpassing the global decline of 9%. This remarkable achievement is highlighted in the National TB Elimination Programme, India TB Report 2024, which provides a comprehensive overview of the nation's efforts to combat this deadly disease.

According to the report, India notified 25.55 lakh cases of TB in 2023, the highest since the launch of the National Tuberculosis Elimination Programme (NTEP) in the 1960s. This milestone underscores the country's commitment to early detection and treatment, which are crucial in curbing the spread of TB.

State-wise Notifications and Private Sector Involvement

The report reveals that Uttar Pradesh recorded the highest number of TB case notifications compared to the previous year, followed closely by Bihar. This highlights the need for targeted interventions and resource allocation in these states to address the burden of TB effectively.

Notably, the private sector played a pivotal role in the fight against TB, with over 8.4 lakh cases being reported from private healthcare facilities in 2023, marking a 1.17% increase from the previous year and a significant rise since 2017. This collaboration between the public and private sectors is crucial in ensuring comprehensive access to TB diagnosis and treatment services across the country.

Treatment Coverage, Mortality, and Achievements

India's treatment coverage for TB improved significantly, reaching 80% of the estimated cases in 2023, representing a 19% increase over the previous year. This remarkable progress reflects the country's dedication to providing accessible and effective treatment options to those affected by the disease.

Furthermore, the report stated that TB mortality in India stood at 23 per lakh population, an 18% decline compared to 2015 when it was 28 per lakh population. This reduction in mortality rates is a testament to the effectiveness of the nation's TB control strategies and the collective efforts of healthcare professionals and stakeholders.

Among the notable achievements, India achieved a case notification rate of approximately 179 cases per lakh population in 2023, narrowing the coverage gap to 0.2 million. Additionally, the NTEP diagnosed 63,939 cases of multidrug-resistant TB (MDR-TB), highlighting its commitment to addressing the challenge of drug resistance.

Active Case-Finding and TB-HIV

Co-infection In 2023, more than 20.5 crore individuals were screened for signs and symptoms suggestive of TB as part of active case-finding efforts. This proactive approach has been instrumental in identifying and treating TB cases early, thereby curbing the spread of the disease.

The report also shed light on the burden of TB-HIV co-infection, a significant public health challenge in India. In 2023, the total number of TB-HIV co-infected cases stood at 34,476, of which 94% and 95% were started on antiretroviral therapy (ART) and Co-trimoxazole Prophylaxis Therapy (CPT) drugs, respectively. This underscores the importance of integrating TB and HIV services to ensure comprehensive care for co-infected individuals.

India's Efforts and Goals for TB Elimination

India has set an ambitious goal of eliminating TB by 2025, five years ahead of the global Sustainable Development Goal (SDG) target of 2030. To achieve this, the country has implemented various strategies and interventions under the National Strategic Plan (NSP) for TB Elimination 2017-2025.

Key efforts include the DOTS (Directly Observed Treatment, Short-course) strategy, which ensures proper diagnosis, treatment, and monitoring of TB patients, as well as the provision of free diagnosis and treatment through the public health system. Additionally, the Nikshay web-based platform facilitates case-based monitoring and management of TB patients, ensuring adherence to treatment and follow-up.

Furthermore, India has made strides in addressing risk factors that contribute to TB infection and poor treatment outcomes. This includes addressing undernourishment, HIV, diabetes, alcohol use, and smoking. The government provides monthly support of Rs 500 to undernourished TB patients, while the Ni-kshay Mitra programme encourages food basket donations.

Despite these efforts, India remains among the eight countries accounting for more than two-thirds (68.3%) of the total TB patients' count, as reported by the World Health Organization (WHO). Continued commitment, collaboration, and targeted interventions are crucial to achieving the goal of TB elimination in India by 2025.

More Related Articles

Elon Musk Uses Ketamine for Depression – How Safe Is It?

Elon Musk uses ketamine to manage depression, a revelation that has sparked discussions on the safety and effectiveness of the drug for mental health treatment. The Tesla and SpaceX CEO has cla

Read CEO Satya nadella's letters to employees

CEO Satya Nadella’s Leadership Strategy Microsoft has recently announced significant shifts in its HR leadership, marking a new chapter under the strategic vision of CEO Satya Nadella. Wi

India Enhances National Defence

The Indian Ministry of Defense (MoD) recently signed contracts worth Rs 10,147 crore to boost the firepower of the Indian Army. These agreements involve the procurement of advanced mu

India’s EV Charging Infrastructure Revolution

The market for electric vehicle (EV) charging is expanding in India. More than $450 million has recently been invested in start-ups that concentrate on battery-swapping models and cha

India's Defense Approach to Lethal Autonomous Weapons Systems

India's Defense Ministry recently conducted a pilot study on Lethal Autonomous Weapons Systems (LAWS), highlighting the transformative potential of these technologies. The study raises

Abolition of Track and Trace System for Pharmaceuticals

The Commerce Ministry has recently decided to discontinue the track and trace system for pharmaceutical exports. This decision is in line with the regulatory framework set by the Mini

Shubhanshu Shukla Becomes India’s First Astronaut to Command Axiom-4 Mission to ISS

Shubhanshu Shukla, an Indian Air Force pilot, is set to become the first Indian astronaut to command a space mission to the ISS as part of Axiom Mission 4 in 2025. In partnership with NASA

India Becomes Observer in Eurodrone Program

India has officially joined the Eurodrone programme as an Observer State. Led by Airbus Defence and Space, the initiative includes Germany, France, Italy, and Spain, and aims to develop a

The Moving Magnetic North Pole: Examining Earth’s Ever-Changing Geomagnetic Field

Recent scientific studies have shown that the Magnetic North Pole is shifting more rapidly, now moving closer to Siberia and continuing its drift toward Russia. Recent scie

M. Mohan Named Director of ISRO's Liquid Propulsion Systems Centre

On January 25, 2025, M. Mohan was appointed as the Director of ISRO's Liquid Propulsion Systems Centre (LPSC) in Thiruvananthapuram, succeeding Dr. V. Narayanan, who assumed the role o

Toppers

anil kumar
Akshay kuamr
geeta kumari
shubham